Evidence check: Leaky Gut Test in the context of Blutzucker

The concept of 'leaky gut' refers to increased intestinal permeability, which is hypothesized to contribute to systemic inflammation and metabolic disturbances, including blood sugar dysregulation. Tests marketed for leaky gut (e.g., stool zonulin, actomyosin IgA) are often promoted to identify gut barrier issues. In the context of blood glucose (Blutzucker), some mechanistic evidence suggests that a compromised gut barrier may allow bacterial fragments to enter circulation, triggering immune responses that worsen insulin resistance. However, the clinical utility of these tests remains unproven. Zonulin levels fluctuate with diet, medications, and stress, making single measurements unreliable. No large-scale, well-controlled trials have demonstrated that acting on leaky gut test results improves glycemic control. Therefore, relying on such tests for blood sugar management is not evidence-based. Established markers like fasting glucose, HbA1c, and OGTT remain the gold standard. A diet rich in fiber, polyphenols, and fermented foods supports both gut health and glucose metabolism more reliably. Leaky gut tests may be considered experimental; their results should be interpreted with caution and not replace standard medical advice. The evidence level is mixed/mechanistic, with limited human data and no strong clinical validation.